Thuy-Van Chau files SEC Form 4 disclosures for Stem Cell Therapy International, Inc.. They have made 1 open-market trade across 1 company since 2009, most recently 2009-09-16.
CIK 0001474725
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SCII | 2,990,000 | — |
Shares reported on the most recent Form 4, priced at the 2009-10-26 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCII | SELL | 2009-09-16 | 2009-10-26 | $0.33 | $2K | N/A | N/A | N/A |